anmelden
FTSE All-Share
5.721,53
PKT
-13,93
PKT
-0,24
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.07.20 | Lloyds Banking Group Neutral | JP Morgan Chase & Co. | |
| 30.07.20 | Shell (ex Royal Dutch Shell) Neutral | JP Morgan Chase & Co. | |
| 30.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.07.20 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 30.07.20 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.07.20 | Lloyds Banking Group Outperform | RBC Capital Markets | |
| 30.07.20 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 30.07.20 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 30.07.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.07.20 | Rio Tinto buy | Deutsche Bank AG | |
| 30.07.20 | GSK Neutral | Credit Suisse Group | |
| 30.07.20 | Barclays Neutral | Credit Suisse Group | |
| 30.07.20 | Barclays buy | Deutsche Bank AG | |
| 30.07.20 | Rio Tinto Neutral | UBS AG | |
| 30.07.20 | Barclays buy | UBS AG | |
| 30.07.20 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 29.07.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 29.07.20 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 29.07.20 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 29.07.20 | AstraZeneca overweight | Barclays Capital | |
| 29.07.20 | Barclays Sector Perform | RBC Capital Markets | |
| 29.07.20 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 29.07.20 | Barclays buy | Jefferies & Company Inc. | |
| 29.07.20 | Barclays overweight | JP Morgan Chase & Co. | |
| 28.07.20 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.07.20 | BT Group Equal weight | Barclays Capital | |
| 28.07.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.07.20 | BP overweight | JP Morgan Chase & Co. | |
| 28.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 27.07.20 | Vodafone Group buy | UBS AG | |
| 27.07.20 | Vodafone Group buy | Deutsche Bank AG | |
| 27.07.20 | HSBC Underweight | JP Morgan Chase & Co. | |
| 27.07.20 | HSBC Underweight | JP Morgan Chase & Co. | |
| 27.07.20 | Prudential buy | UBS AG | |
| 27.07.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.07.20 | Unilever buy | Jefferies & Company Inc. | |
| 27.07.20 | Unilever buy | Jefferies & Company Inc. | |
| 27.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 27.07.20 | Vodafone Group Outperform | Credit Suisse Group | |
| 27.07.20 | National Grid buy | Jefferies & Company Inc. |